Get a quote

We're excited to learn more about your project and provide you with a customized quote tailored to your needs. Please fill out the form below, and we'll get back to you as soon as possible.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Porcine Creatine Kinase MB Isoenzyme (CKMB) ELISA Kit-Sandwich

Cat. No.EK12F788

Product TypeAnimal Immunoassay Kits

Size

Product Overview

BioVenic Porcine Creatine Kinase MB Isoenzyme(CKMB) ELISA Kit-Sandwich is designed for the quantitative determination of Porcine Creatine Kinase MB Isoenzyme(CKMB) in serum, plasma, tissue homogenate, cell culture supernatant, cell extract, and other biological fluids using a Sandwich ELISA method. For research use only.

Specifications

Assay Type ELISA-Sandwich
Specificity The assay kit is specific for Porcine CKMB.
Target Species Swine
Species Reactivity Swine
Detection Range 0.234-15 ng/mL
Sensitivity 0.141ng/mL
Reproducibility Intra-Assay: CV < 10%; Inter-Assay: CV < 10%
Assay Time Around 270 min
Sample Requirement Serum, plasma, tissue homogenate, cell culture supernatant, cell extract, and other biological fluids.

Target Information

Creatine kinase MB isoenzyme (CK-MB) is predominantly expressed in the myocardium. CK-MB plays a crucial role in energy metabolism within cardiac muscle. It catalyzes the conversion of creatine phosphate to adenosine triphosphate (ATP) during muscle contraction. CK-MB levels are measured in the blood to assess heart muscle damage. Serum CK-MB levels have been used to evaluate patients with suspected acute myocardial infarction.

Target/Biomarker Porcine CKMB
Target Synonym CKMB; Creatine Kinase MB Isoenzyme; CK-MB

Shipping and Storage

This product is shipped with gel ice packs. It is recommended to store at 2-8 °C (Up to 6 months).

Documents

COA

To request a Certificate of Analysis, please enter the Lot No. in the search box. Note: Certificate of Analysis not available for kits.

The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.

References

  1. Kittipeerapat, N. et al. Creatine Kinase MB Isoenzyme Is a Complementary Biomarker in Amyotrophic Lateral Sclerosis. International journal of molecular sciences. 2023, 24: 11682.
Inquiry Basket